ProfileGDS5822 / ILMN_2616422
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 79% 74% 79% 79% 74% 81% 68% 80% 79% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1116.179
GSM1276600PDAC Late Ablation Control 281.374
GSM1276601PDAC Late Ablation Control 3180.579
GSM1276602PDAC Late Ablation 1128.379
GSM1276603PDAC Late Ablation 28574
GSM1276604PDAC Late Ablation 3178.481
GSM1303940PDAC Late Ablation_anti-CTLA4 140.668
GSM1303941PDAC Late Ablation_anti-CTLA4 2175.580
GSM1303942PDAC Late Ablation_anti-CTLA4 3172.979